Fixed drug eruption caused by fulvestrant confirmed by skin tests: First case

Contact Dermatitis. 2019 Mar;80(3):184-186. doi: 10.1111/cod.13161. Epub 2018 Nov 21.

Authors

Clémentine Broche¹, Pauline Pralong¹, Hugo Gil², Nassima Yahiaoui³, Mireille Mousseau⁴, Catharina Chatain¹, Jean-Pierre Jacquier¹, Julie Charles¹, Marie-Thérèse Leccia¹

Affiliations

¹ Dermatology, Allergology and Photobiology Department, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France.
² Anatomopathology Department, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France.
³ Regional Pharmacovigilance, Addictovigilance Department, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France.
⁴ Oncology Department, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France.

PMID: 30461027
DOI: 10.1111/cod.13161

No abstract available

Keywords: breast cancer; case report; fixed drug eruption; fulvestrant; skin testing.

Publication types

Case Reports

MeSH terms

Aged
Antineoplastic Agents, Hormonal / adverse effects*
Drug Eruptions / etiology*
Drug Eruptions / pathology
Female
Fulvestrant / adverse effects*
Humans
Patch Tests

Substances

Antineoplastic Agents, Hormonal
Fulvestrant